Literature DB >> 19589783

Cyclosporin A decreases apolipoprotein E secretion from human macrophages via a protein phosphatase 2B-dependent and ATP-binding cassette transporter A1 (ABCA1)-independent pathway.

Maaike Kockx1, Dongni Lily Guo, Mathew Traini, Katharina Gaus, Jason Kay, Sabine Wimmer-Kleikamp, Carles Rentero, John R Burnett, Wilfried Le Goff, Miranda Van Eck, Jennifer L Stow, Wendy Jessup, Leonard Kritharides.   

Abstract

Cyclosporin A (CsA) is an immunosuppressant that inhibits protein phosphatase 2B (PP2B/calcineurin) and is associated with hyperlipidemia, decreased cholesterol efflux via ATP-binding cassette transporter A1 (ABCA1), and increased risk of atherosclerosis. Apolipoprotein E (apoE) is an important regulator of lipid metabolism and atherosclerosis, the secretion of which from human macrophages is regulated by the serine/threonine protein kinase A (PKA) and intracellular calcium (Ca(2+)) (Kockx, M., Guo, D. L., Huby, T., Lesnik, P., Kay, J., Sabaretnam, T., Jary, E., Hill, M., Gaus, K., Chapman, J., Stow, J. L., Jessup, W., and Kritharides, L. (2007) Circ. Res. 101, 607-616). As PP2B is Ca(2+)-dependent and has been linked to PKA-dependent processes, we investigated whether CsA modulated apoE secretion. CsA dose- and time-dependently inhibited secretion of apoE from primary human macrophages and from Chinese hamster ovary cells stably transfected with human apoE and increased cellular apoE levels without affecting apoE mRNA. [(35)S]Met kinetic modeling studies showed that CsA inhibited both secretion and degradation of apoE, increasing the half-life of cellular apoE 2-fold. CsA also inhibited secretion from primary human Tangier disease macrophages and from mouse macrophages deficient in ABCA1, indicating that the effect is independent of the known inhibition of ABCA1 by CsA. The role of PP2B in mediating apoE secretion was confirmed using additional peptide and chemical inhibitors of PP2B. Importantly, kinetic modeling, live-cell imaging, and confocal microscopy all indicated that CsA inhibited apoE secretion by mechanisms quite distinct from those of PKA inhibition, most likely inducing accumulation of apoE in the endoplasmic reticulum compartment. Taken together, these results establish a novel mechanism for the pro-atherosclerotic effects of CsA, and establish for the first time a role for PP2B in regulating the intracellular transport and secretion of apoE.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19589783      PMCID: PMC2782008          DOI: 10.1074/jbc.M109.032615

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

Review 1.  Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E.

Authors:  R W Mahley; Z S Ji
Journal:  J Lipid Res       Date:  1999-01       Impact factor: 5.922

Review 2.  The mechanism of action of cyclosporin A and FK506.

Authors:  S Ho; N Clipstone; L Timmermann; J Northrop; I Graef; D Fiorentino; J Nourse; G R Crabtree
Journal:  Clin Immunol Immunopathol       Date:  1996-09

3.  A kinetic model to evaluate cholesterol efflux from THP-1 macrophages to apolipoprotein A-1.

Authors:  K Gaus; J J Gooding; R T Dean; L Kritharides; W Jessup
Journal:  Biochemistry       Date:  2001-08-07       Impact factor: 3.162

4.  Regulation of macrophage ApoE expression and processing by extracellular matrix.

Authors:  Yuwei Zhao; Lili Yue; DeSheng Gu; Theodore Mazzone
Journal:  J Biol Chem       Date:  2002-05-28       Impact factor: 5.157

Review 5.  Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease.

Authors:  Robert W Mahley; Karl H Weisgraber; Yadong Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

6.  Degradation of macrophage ApoE in a nonlysosomal compartment. Regulation by sterols.

Authors:  H Duan; C Y Lin; T Mazzone
Journal:  J Biol Chem       Date:  1997-12-05       Impact factor: 5.157

Review 7.  The key role of apolipoprotein E in atherosclerosis.

Authors:  Kirsty Greenow; Nigel J Pearce; Dipak P Ramji
Journal:  J Mol Med (Berl)       Date:  2005-04-13       Impact factor: 4.599

8.  A pathway-dependent on apoE, ApoAI, and ABCA1 determines formation of buoyant high-density lipoprotein by macrophage foam cells.

Authors:  Patricia G Yancey; Hong Yu; MacRae F Linton; Sergio Fazio
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-02-15       Impact factor: 8.311

Review 9.  ATP-Binding cassette cholesterol transporters and cardiovascular disease.

Authors:  John F Oram; Ashley M Vaughan
Journal:  Circ Res       Date:  2006-11-10       Impact factor: 17.367

10.  Trypsin-sensitive and lipid-containing sites of the macrophage extracellular matrix bind apolipoprotein A-I and participate in ABCA1-dependent cholesterol efflux.

Authors:  Jim W Burgess; Robert S Kiss; Hui Zheng; Susha Zachariah; Yves L Marcel
Journal:  J Biol Chem       Date:  2002-06-05       Impact factor: 5.157

View more
  10 in total

1.  Protein kinase A modulates the activity of a major human isoform of ABCG1.

Authors:  Ingrid C Gelissen; Laura J Sharpe; Cecilia Sandoval; Geetha Rao; Maaike Kockx; Leonard Kritharides; Wendy Jessup; Andrew J Brown
Journal:  J Lipid Res       Date:  2012-08-07       Impact factor: 5.922

Review 2.  Cell-specific production, secretion, and function of apolipoprotein E.

Authors:  Maaike Kockx; Mathew Traini; Leonard Kritharides
Journal:  J Mol Med (Berl)       Date:  2018-03-07       Impact factor: 4.599

Review 3.  Molecular and cellular mechanism of okadaic acid (OKA)-induced neurotoxicity: a novel tool for Alzheimer's disease therapeutic application.

Authors:  Pradip K Kamat; Shivika Rai; Supriya Swarnkar; Rakesh Shukla; Chandishwar Nath
Journal:  Mol Neurobiol       Date:  2014-04-08       Impact factor: 5.590

4.  Inhibition of T cells provides protection against early invasive pneumococcal disease.

Authors:  Kim LeMessurier; Hans Häcker; Elaine Tuomanen; Vanessa Redecke
Journal:  Infect Immun       Date:  2010-09-20       Impact factor: 3.441

5.  Leukocyte Ig-like receptor B4 (LILRB4) is a potent inhibitor of FcgammaRI-mediated monocyte activation via dephosphorylation of multiple kinases.

Authors:  Hao Kim Lu; Carles Rentero; Mark J Raftery; Luis Borges; Katherine Bryant; Nicodemus Tedla
Journal:  J Biol Chem       Date:  2009-10-15       Impact factor: 5.157

6.  Protein kinase C controls vesicular transport and secretion of apolipoprotein E from primary human macrophages.

Authors:  Denuja Karunakaran; Maaike Kockx; Dylan M Owen; John R Burnett; Wendy Jessup; Leonard Kritharides
Journal:  J Biol Chem       Date:  2013-01-03       Impact factor: 5.157

7.  Sphingomyelin phosphodiesterase acid-like 3A (SMPDL3A) is a novel nucleotide phosphodiesterase regulated by cholesterol in human macrophages.

Authors:  Mathew Traini; Carmel M Quinn; Cecilia Sandoval; Erik Johansson; Kate Schroder; Maaike Kockx; Peter J Meikle; Wendy Jessup; Leonard Kritharides
Journal:  J Biol Chem       Date:  2014-10-06       Impact factor: 5.157

8.  Cyclosporine A impairs the macrophage reverse cholesterol transport in mice by reducing sterol fecal excretion.

Authors:  Ilaria Zanotti; Daniela Greco; Giulia Lusardi; Francesca Zimetti; Francesco Potì; Lorenzo Arnaboldi; Alberto Corsini; Franco Bernini
Journal:  PLoS One       Date:  2013-08-09       Impact factor: 3.240

9.  Pharmacological inhibition of dynamin II reduces constitutive protein secretion from primary human macrophages.

Authors:  Maaike Kockx; Denuja Karunakaran; Mathew Traini; Jing Xue; Kuan Yen Huang; Diana Nawara; Katharina Gaus; Wendy Jessup; Phillip J Robinson; Leonard Kritharides
Journal:  PLoS One       Date:  2014-10-27       Impact factor: 3.240

Review 10.  Molecular Insight into the Therapeutic Promise of Targeting APOE4 for Alzheimer's Disease.

Authors:  Abdullah Al Mamun; Md Sahab Uddin; Md Fahim Bin Bashar; Sonia Zaman; Yesmin Begum; Israt Jahan Bulbul; Md Siddiqul Islam; Md Shahid Sarwar; Bijo Mathew; Md Shah Amran; Ghulam Md Ashraf; May N Bin-Jumah; Shaker A Mousa; Mohamed M Abdel-Daim
Journal:  Oxid Med Cell Longev       Date:  2020-05-15       Impact factor: 6.543

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.